Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
35
Number of overlapping holdings
94.6%
% of IHE's 38 holdings also in XPH
83.3%
% of XPH's 42 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 5.5% | 4.3% | 4.3% |
|
VIATRIS, INC. | 5.3% | 4.1% | 4.1% |
|
CATALENT INC | 4.7% | 4.0% | 4.0% |
|
ZOETIS INC | 4.5% | 3.5% | 3.5% |
|
ROYALTY PHARMA PLC CLASS A | 4.0% | 3.4% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to XPH
|
JOHNSON & JOHNSON | 17.8% |
|
ELI LILLY & CO | 17.2% |
|
VIATRIS, INC. | 1.2% |
|
BRISTOL-MYERS SQUIBB CO | 1.2% |
|
ZOETIS INC | 0.9% |
|
MERCK & CO. INC. | 0.9% |
|
PFIZER INC | 0.8% |
|
CATALENT INC | 0.7% |
|
ROYALTY PHARMA PLC CLASS A | 0.6% |
 |
THERAVANCE BIOPHARMA INC | 0.1% |
IHE Underweight Relative to XPH
|
CORCEPT THERAPEUTICS INC | -3.4% |
|
TARSUS PHARMACEUTICALS, INC. | -2.7% |
|
EDGEWISE THERAPEUTICS, INC. | -2.5% |
 |
PERRIGO CO | -2.2% |
|
PACIRA PHARMACEUTICALS INC | -2.2% |
|
AXSOME THERAPEUTICS, INC. | -2.1% |
|
ARVINAS, INC. | -1.7% |
|
SUPERNUS PHARMACEUTICALS INC | -1.5% |
|
AMPHASTAR PHARMACEUTICALS INC | -1.4% |
|
OCULAR THERAPEUTIX INC | -1.4% |